High-Definition Erenna® Immunoassay System
The Erenna Immunoassay System, powered by Singulex's patented single-molecule detection technology, accelerates biomedical and translational research by accurately and reliably quantifying low-abundance biomarkers at or below sub-picogram concentrations. This unique high-definition technology enables distinct stratification of healthy and disease subjects through a broad dynamic range of over 4 logs, enhancing the clinical utility of biomarkers and allowing researchers to gain insights into drug safety and efficacy.
The Erenna Immunoassay System includes fully equipped benchtop analytical instrumentation, integrated and prepared reagents for ultrasensitive immunoassays, and dedicated software to automatically analyze data and display detailed assay reports.
The Erenna Immunoassay System uses a robust digital molecule-counting module to count photons, where ultra-sensitive fluorescence is measured in the presence of proprietary background reduction methodology. A large dynamic range of 4+ logs is obtained by combining single-molecule counting (low range) with photon counting (mid range) and total light measurements (high range).
Application notes and news
- Cardiotoxicity: Elevations of Cardiac Troponin-I Quantified with the Erenna cTnl Immunoassay
- New Data from TIMI Study Group to Be Presented at American College of Cardiology Scientific Session Show Pr...
- Singulex Adds Interleuken-17a/F To Powerful Suite Of TH17 Pathway Immunoassay Kits
- Highly Sensitive Cardiac Troponin-I Assay Could Identify Future Risk for Dying from Cardiovascular Disease